NG BIOTECH

medical devices

About

NG Biotech is a French biotechnology company focused on developing, manufacturing, and commercializing innovative in vitro diagnostic tools for therapy monitoring at the point of care. They have created a patented immunoassay platform that allows for rapid, mobile, and connected diagnostics using direct biological samples, such as a drop of blood, providing results in minutes. Their core products include rapid diagnostic tests, particularly lateral flow immunoassays, which are CE marked and validated against laboratory standards. The company specializes in areas such as antimicrobial resistance, infectious diseases, and women’s health. Their leading product, NG-TEST® CTX-M MULTI, has received FDA 510(k) clearance for the rapid detection of CTX-M groups. NG Biotech also integrates wireless mobile readers for data sharing and management, supporting modern healthcare needs. With a production capacity exceeding 4 million tests per month and a presence in over 70 countries, including the US and China, NG Biotech is committed to advancing rapid diagnostics in both human and animal health, as well as agriculture and biodefense.

Technologies

Outlook Microsoft Office 365 AI

Keywords

mhealth ehealth amr ivd diagnostics otc antimicrobialresistance womenhealth point of care biotechnology blood test esbl detection clinical microbiology sample preparation multiplex immunoassay healthcare b2b medical equipment and supplies manufacturing medical devices candida auris detection ce marked antimicrobial resistance detection point of care testing lateral flow immunoassay diagnostic development hospital laboratory colistin resistance resistance mechanism detection veterinary carbapenemase detection

Location

Lieuron, Brittany, France, 35550

Related Companies

Companies in the same industry